Product Code: ETC13359654 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Human Fibrinogen Concentrate Market was valued at USD 14.1 Billion in 2024 and is expected to reach USD 22.9 Billion by 2031, growing at a compound annual growth rate of 5.70% during the forecast period (2025-2031).
The Global Human Fibrinogen Concentrate Market is experiencing steady growth, driven by increasing prevalence of bleeding disorders, surgical procedures, and trauma cases worldwide. Fibrinogen concentrate is widely used in the treatment of congenital fibrinogen deficiencies, acquired fibrinogen deficiencies, and as a hemostatic agent during surgery. The market is also benefiting from advancements in biotechnology and healthcare infrastructure in developing countries. Key players in the market are focusing on product innovations, strategic partnerships, and expanding their distribution networks to gain a competitive edge. However, stringent regulatory requirements and high costs associated with fibrinogen concentrate products could potentially hinder market growth. Overall, the Global Human Fibrinogen Concentrate Market is projected to show significant growth in the coming years, driven by increasing awareness about bleeding disorders and rising healthcare expenditures globally.
The Global Human Fibrinogen Concentrate Market is witnessing steady growth due to the increasing prevalence of bleeding disorders and surgical procedures that require fibrinogen supplementation. The market is driven by advancements in fibrinogen concentrate formulations, such as cryoprecipitate-derived and recombinant products, which offer improved safety and efficacy. Additionally, the rising awareness about the benefits of fibrinogen concentrate in managing bleeding episodes and the expanding applications in trauma care and cardiovascular surgeries are creating significant opportunities for market growth. Furthermore, strategic collaborations between key players, expanding healthcare infrastructure in emerging economies, and the growing demand for plasma-derived products are expected to further fuel market expansion in the coming years.
The Global Human Fibrinogen Concentrate Market faces several challenges, including stringent regulatory requirements for product approval, high costs associated with production and storage, limited availability of plasma donors, and the risk of transmission of infectious diseases. Additionally, there is a lack of awareness about fibrinogen concentrate among healthcare professionals and patients, leading to underdiagnosis and under-treatment of fibrinogen deficiency disorders. Competition from alternative treatment options, such as cryoprecipitate and recombinant fibrinogen products, further adds to the challenges faced by manufacturers in this market. Overall, addressing these challenges will require continuous innovation, investment in research and development, and collaboration between industry stakeholders to improve access to fibrinogen concentrate therapy globally.
The global human fibrinogen concentrate market is primarily driven by the increasing prevalence of bleeding disorders such as hemophilia and congenital fibrinogen deficiency. The rising number of surgical procedures, including cardiovascular surgeries and trauma cases, also contribute to the demand for fibrinogen concentrate as a hemostatic agent. Additionally, advancements in biotechnology and pharmaceutical research have led to the development of innovative fibrinogen concentrate products with improved efficacy and safety profiles, further bolstering market growth. Moreover, the expanding geriatric population, who are more susceptible to coagulation disorders, is expected to drive the market in the coming years. Overall, the demand for human fibrinogen concentrate is expected to continue to rise due to the increasing awareness about bleeding disorders and the growing need for effective hemostatic treatments.
Government policies related to the Global Human Fibrinogen Concentrate Market primarily focus on ensuring safety, efficacy, and quality standards of products. Regulatory bodies such as the FDA in the United States and the EMA in Europe have specific guidelines in place for the approval and marketing of fibrinogen concentrate products. These regulations cover aspects such as manufacturing practices, labeling requirements, and post-market surveillance to monitor any adverse events. Additionally, government policies may also address pricing and reimbursement considerations to ensure access to fibrinogen concentrate for patients in need. It is essential for companies operating in this market to comply with these regulations to maintain market authorization and ensure patient safety.
The global human fibrinogen concentrate market is expected to witness steady growth in the coming years, driven by increasing incidences of bleeding disorders, surgeries, and trauma cases. The rising adoption of fibrinogen concentrate as a treatment option for patients with congenital fibrinogen deficiency is also contributing to market expansion. Furthermore, advancements in healthcare infrastructure, growing awareness about the benefits of fibrinogen concentrate in managing bleeding episodes, and ongoing research and development activities are anticipated to fuel market growth. However, challenges such as high costs associated with fibrinogen concentrate products and stringent regulatory requirements may hinder market growth to some extent. Overall, the market is projected to experience moderate yet consistent growth due to a rising demand for effective hemostatic treatments globally.
In the global human fibrinogen concentrate market, Asia Pacific is expected to witness the fastest growth due to the increasing prevalence of bleeding disorders and rising healthcare expenditure in countries like China and India. North America holds a significant market share owing to the presence of advanced healthcare infrastructure and a high adoption rate of novel therapeutics. Europe is also a key market, driven by the growing geriatric population and the rising awareness about the benefits of fibrinogen concentrate in surgical procedures. The Middle East and Africa region is projected to experience steady growth, supported by improving healthcare facilities and the rising incidence of trauma cases. Latin America is poised for moderate growth due to increasing healthcare investments and the expanding patient pool with bleeding disorders.
Global Human Fibrinogen Concentrate Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Human Fibrinogen Concentrate Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Human Fibrinogen Concentrate Market Revenues & Volume, 2021 & 2031F |
3.3 Global Human Fibrinogen Concentrate Market - Industry Life Cycle |
3.4 Global Human Fibrinogen Concentrate Market - Porter's Five Forces |
3.5 Global Human Fibrinogen Concentrate Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Human Fibrinogen Concentrate Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Human Fibrinogen Concentrate Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.8 Global Human Fibrinogen Concentrate Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Global Human Fibrinogen Concentrate Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.10 Global Human Fibrinogen Concentrate Market Revenues & Volume Share, By Concentration, 2021 & 2031F |
4 Global Human Fibrinogen Concentrate Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Human Fibrinogen Concentrate Market Trends |
6 Global Human Fibrinogen Concentrate Market, 2021 - 2031 |
6.1 Global Human Fibrinogen Concentrate Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Human Fibrinogen Concentrate Market, Revenues & Volume, By Plasma-derived, 2021 - 2031 |
6.1.3 Global Human Fibrinogen Concentrate Market, Revenues & Volume, By Recombinant, 2021 - 2031 |
6.1.4 Global Human Fibrinogen Concentrate Market, Revenues & Volume, By Synthetic, 2021 - 2031 |
6.2 Global Human Fibrinogen Concentrate Market, Revenues & Volume, By Source, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Human Fibrinogen Concentrate Market, Revenues & Volume, By Human Plasma, 2021 - 2031 |
6.2.3 Global Human Fibrinogen Concentrate Market, Revenues & Volume, By Recombinant, 2021 - 2031 |
6.2.4 Global Human Fibrinogen Concentrate Market, Revenues & Volume, By Synthetic, 2021 - 2031 |
6.3 Global Human Fibrinogen Concentrate Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Human Fibrinogen Concentrate Market, Revenues & Volume, By Hemophilia, 2021 - 2031 |
6.3.3 Global Human Fibrinogen Concentrate Market, Revenues & Volume, By Blood Coagulation, 2021 - 2031 |
6.3.4 Global Human Fibrinogen Concentrate Market, Revenues & Volume, By Trauma Treatment, 2021 - 2031 |
6.4 Global Human Fibrinogen Concentrate Market, Revenues & Volume, By Dosage Form, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Human Fibrinogen Concentrate Market, Revenues & Volume, By Injection, 2021 - 2031 |
6.4.3 Global Human Fibrinogen Concentrate Market, Revenues & Volume, By IV Infusion, 2021 - 2031 |
6.4.4 Global Human Fibrinogen Concentrate Market, Revenues & Volume, By Injectable, 2021 - 2031 |
6.5 Global Human Fibrinogen Concentrate Market, Revenues & Volume, By Concentration, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Human Fibrinogen Concentrate Market, Revenues & Volume, By High, 2021 - 2031 |
6.5.3 Global Human Fibrinogen Concentrate Market, Revenues & Volume, By Medium, 2021 - 2031 |
6.5.4 Global Human Fibrinogen Concentrate Market, Revenues & Volume, By Low, 2021 - 2031 |
7 North America Human Fibrinogen Concentrate Market, Overview & Analysis |
7.1 North America Human Fibrinogen Concentrate Market Revenues & Volume, 2021 - 2031 |
7.2 North America Human Fibrinogen Concentrate Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Human Fibrinogen Concentrate Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Human Fibrinogen Concentrate Market, Revenues & Volume, By Source, 2021 - 2031 |
7.5 North America Human Fibrinogen Concentrate Market, Revenues & Volume, By Application, 2021 - 2031 |
7.6 North America Human Fibrinogen Concentrate Market, Revenues & Volume, By Dosage Form, 2021 - 2031 |
7.7 North America Human Fibrinogen Concentrate Market, Revenues & Volume, By Concentration, 2021 - 2031 |
8 Latin America (LATAM) Human Fibrinogen Concentrate Market, Overview & Analysis |
8.1 Latin America (LATAM) Human Fibrinogen Concentrate Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Human Fibrinogen Concentrate Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Human Fibrinogen Concentrate Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Human Fibrinogen Concentrate Market, Revenues & Volume, By Source, 2021 - 2031 |
8.5 Latin America (LATAM) Human Fibrinogen Concentrate Market, Revenues & Volume, By Application, 2021 - 2031 |
8.6 Latin America (LATAM) Human Fibrinogen Concentrate Market, Revenues & Volume, By Dosage Form, 2021 - 2031 |
8.7 Latin America (LATAM) Human Fibrinogen Concentrate Market, Revenues & Volume, By Concentration, 2021 - 2031 |
9 Asia Human Fibrinogen Concentrate Market, Overview & Analysis |
9.1 Asia Human Fibrinogen Concentrate Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Human Fibrinogen Concentrate Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Human Fibrinogen Concentrate Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Human Fibrinogen Concentrate Market, Revenues & Volume, By Source, 2021 - 2031 |
9.5 Asia Human Fibrinogen Concentrate Market, Revenues & Volume, By Application, 2021 - 2031 |
9.6 Asia Human Fibrinogen Concentrate Market, Revenues & Volume, By Dosage Form, 2021 - 2031 |
9.7 Asia Human Fibrinogen Concentrate Market, Revenues & Volume, By Concentration, 2021 - 2031 |
10 Africa Human Fibrinogen Concentrate Market, Overview & Analysis |
10.1 Africa Human Fibrinogen Concentrate Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Human Fibrinogen Concentrate Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Human Fibrinogen Concentrate Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Human Fibrinogen Concentrate Market, Revenues & Volume, By Source, 2021 - 2031 |
10.5 Africa Human Fibrinogen Concentrate Market, Revenues & Volume, By Application, 2021 - 2031 |
10.6 Africa Human Fibrinogen Concentrate Market, Revenues & Volume, By Dosage Form, 2021 - 2031 |
10.7 Africa Human Fibrinogen Concentrate Market, Revenues & Volume, By Concentration, 2021 - 2031 |
11 Europe Human Fibrinogen Concentrate Market, Overview & Analysis |
11.1 Europe Human Fibrinogen Concentrate Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Human Fibrinogen Concentrate Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Human Fibrinogen Concentrate Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Human Fibrinogen Concentrate Market, Revenues & Volume, By Source, 2021 - 2031 |
11.5 Europe Human Fibrinogen Concentrate Market, Revenues & Volume, By Application, 2021 - 2031 |
11.6 Europe Human Fibrinogen Concentrate Market, Revenues & Volume, By Dosage Form, 2021 - 2031 |
11.7 Europe Human Fibrinogen Concentrate Market, Revenues & Volume, By Concentration, 2021 - 2031 |
12 Middle East Human Fibrinogen Concentrate Market, Overview & Analysis |
12.1 Middle East Human Fibrinogen Concentrate Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Human Fibrinogen Concentrate Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Human Fibrinogen Concentrate Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Human Fibrinogen Concentrate Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Human Fibrinogen Concentrate Market, Revenues & Volume, By Source, 2021 - 2031 |
12.5 Middle East Human Fibrinogen Concentrate Market, Revenues & Volume, By Application, 2021 - 2031 |
12.6 Middle East Human Fibrinogen Concentrate Market, Revenues & Volume, By Dosage Form, 2021 - 2031 |
12.7 Middle East Human Fibrinogen Concentrate Market, Revenues & Volume, By Concentration, 2021 - 2031 |
13 Global Human Fibrinogen Concentrate Market Key Performance Indicators |
14 Global Human Fibrinogen Concentrate Market - Export/Import By Countries Assessment |
15 Global Human Fibrinogen Concentrate Market - Opportunity Assessment |
15.1 Global Human Fibrinogen Concentrate Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Human Fibrinogen Concentrate Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Human Fibrinogen Concentrate Market Opportunity Assessment, By Source, 2021 & 2031F |
15.4 Global Human Fibrinogen Concentrate Market Opportunity Assessment, By Application, 2021 & 2031F |
15.5 Global Human Fibrinogen Concentrate Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
15.6 Global Human Fibrinogen Concentrate Market Opportunity Assessment, By Concentration, 2021 & 2031F |
16 Global Human Fibrinogen Concentrate Market - Competitive Landscape |
16.1 Global Human Fibrinogen Concentrate Market Revenue Share, By Companies, 2024 |
16.2 Global Human Fibrinogen Concentrate Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |